Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has been ...

Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1 million in 2025 and an impressive US$3,261.7 million ...

Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...

Biotium, a leading provider of fluorescent reagents for life science research, has expanded its trusted Cheetah™ Taq DNA Polymerase line with two powerful new formulations: Cheetah™ FLEX ...

A study finds DNA damage and threats to cellular health with occupational exposure of farmers and farmworkers.